Makers of these drugs recommend having a conversation about the side effect profile and personalized risks with a healthcare professional before starting
Participants in these trials, many struggling with obesity for years, achieved notable reductions in body weight compared to placebo groups
This enhanced safety profile allows individuals to manage their condition effectively without compromising their overall well-being
Mounjaro is personalised by healthcare providers, with dosing tailored to each patients needs, offering a structured approach for adults living with obesity or overweight conditions alongside lifestyle changes
This gap matters because the assumptions underlying microdosing, that lower starting doses reduce side effects while preserving the gradual receptor adaptation that makes titration effective, remain assumptions
"For Lilly, this is surely progress, but for many patients, at least in the near term, Im not so sure," Alliance for Pharmacy Compounding CEO Scott Brunner said in a statement